2030 年 3D 細胞培養支架市場預測:按類型、用途和地區分類的全球分析
市場調查報告書
商品編碼
1371981

2030 年 3D 細胞培養支架市場預測:按類型、用途和地區分類的全球分析

3D Cell Culture Scaffold Market Forecasts to 2030 - Global Analysis By Type (Fiber, Hydrogel, Decellularized Scaffolds, Synthetic Polymers and Other Types), Application and By Geography

出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據,全球 3D 細胞培養支架市場預計在預測期內將以 17.0% 的年複合成長率成長。

涉及3D(3D)細胞培養支架或基質的製造、銷售和應用的全球產業被稱為「3D細胞培養支架市場」。這些支架為細胞在三個維度上的發育、增殖和分化提供了有利的環境,與活體組織和器官中的條件非常相似。該市場包括各種合成聚合物、去細胞組織、水凝膠以及用於製造這些 3D 結構的其他材料和技術。

根據美國國立衛生研究院的數據,2020 年各種生物工程技術的總投資達 5,646 美元,高於 2019 年的 5,091 美元。根據美國衛生資源與服務管理局網站「organdonor.gov」顯示,截至2021年10月,2020年美國等待器官移植的患者人數為107,103人。

再生醫學及組織工程

人們對再生醫學和組織工程應用的興趣日益濃厚,為 3D 細胞培養支架促進生產用於移植的功能性組織和器官提供了機會。此外,藥物開發中對更可靠的體外模型的需求不斷成長,並且有機會建立更好的預測工具來測試藥物功效和安全性。

成本、標準化和複雜性

由於支架材料和技術多種多樣,很難為使用 3D 細胞培養支架的研究創建標準化方案。然而,由於它們比傳統的 2D 培養技術更昂貴,因此3D 細胞培養支架和相關技術可能不會被廣泛使用,特別是在資源有限的環境中。

技術和癌症研究的進步

隨著 3D 細胞培養技術(包括基於支架的方法)的不斷發展,體外細胞模型的準確性和生理有效性正在提高,從而增加了對支架的需求。此外,在癌症研究和藥物試驗中,基於支架的 3D 細胞培養模型可以實現更複雜、更真實的腫瘤模型,從而帶來更好的治療方法。

法規牆

我們的 3D 細胞培養支架業務受到法規延誤和成本增加的影響,特別是在用於藥物測試和安全評估時。複雜的法規可能適用於 3D 細胞培養模型的使用,特別是在藥物開發和毒性測試中。遵守這些法規並獲得必要的核准可能需要大量的資源和時間。

新冠肺炎 (COVID-19) 影響:

由於全球供應線中斷,疫情影響了製造 3D 細胞培養支架的基本材料和組件的供應。結果,製造商遭遇了延誤和成本增加。由於經濟不確定性,疫情期間研發部門的預算限制可能影響了 3D 細胞培養支架的投資。

合成聚合物領域預計將在預測期內成為最大的領域

預計合成聚合物領域在預測期內將佔據最大佔有率。合成聚合物領域是 3D 細胞培養支架市場的關鍵結構要素,提供各種具有特定品質的工程材料,用於開發 3D 細胞培養環境。此外,合成聚合物由於其多功能性和生物相容性而非常重要,可以為個體化治療創造複雜的細胞培養條件。合成聚合物透過促進功能組織和器官的發育,為推進再生醫學提供了機會。

預計生物製藥領域在預測期內將出現最高的年複合成長率。

預計生物製藥領域的年複合成長率最高。生物製藥公司使用 3D 細胞培養支架來加速藥物研發發現和開發過程。這些支架能夠更準確地模擬體內情況,並能夠更準確地評估候選藥物的功效和安全性。此外,它對於創建生理上準確的細胞模型以用於毒性、癌症和標靶藥物設計的研究至關重要。 3D 細胞培養支架市場正在幫助生物製藥公司追求個人化醫療,讓他們可以根據個別患者的反應來客製化藥物。

佔比最高的地區

亞太地區所佔比例最高。隨著該地區發展成為醫療旅遊和高科技醫療服務中心,依賴 3D 細胞培養模型的精準醫療和組織再生變得越來越重要。此外,中國和印度等國家的強勁經濟成長正在推動醫療保健和生命科學領域的投資,從而推動對尖端細胞培養技術的需求。

複合年複合成長率最高的地區:

亞太地區預計將快速成長。由於該地區心血管疾病的流行,血管生物學研究和 3D 細胞培養支架的製造正在進行中,以更好地了解這些疾病並制定治療方法。此外,亞太地區的製藥部門正在使用 3D 細胞培養模型來測試心血管療法並評估它們如何影響血管生物學,以幫助藥物開發。

免費客製化服務

訂閱此報告的客戶可以存取以下免費自訂選項之一:

  • 公司簡介
    • 其他市場參與者的綜合分析(最多 3 家公司)
    • 主要企業SWOT分析(最多3家企業)
  • 區域分割
    • 根據客戶意願對主要國家的市場估計、預測和年複合成長率(註:基於可行性檢查)
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 利害關係人
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 應用分析
  • 新興市場
  • 新型冠狀病毒感染疾病(COVID-19)的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球3D 細胞培養支架市場:依類型

  • 纖維
  • 水凝膠
  • 去細胞支架
  • 合成聚合物
  • 其他類型

第6章 全球3D 細胞培養支架市場:依應用分類

  • 生物製藥
  • 科學研究
  • 血管生物學
  • 人體組織工程
  • 藥物研發發現與開發
  • 生物列印
  • 其他用途

第7章 全球3D 細胞培養支架市場:依地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第8章 進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第9章 公司簡介

  • 3D Biotek
  • Corning Incorporated
  • Greiner Bio-One
  • InSphero AG
  • Lonza Group
  • Merck KGaA
  • N3d Bioscience
  • Nanofiber Solutions
  • Reprocell Incorporated
  • Synthecon Incorporated
  • TARA Biosystems
  • Thermo Fisher Scientific
Product Code: SMRC24037

According to Stratistics MRC, the Global 3D Cell Culture Scaffold Market is expected to grow at a CAGR of 17.0% during the forecast period. The global industry for the manufacture, sale, and application of three-dimensional (3D) cell culture scaffolds or matrices is known as the "3D Cell Culture Scaffold Market." These scaffolds offer an environment that is favorable to cell development, proliferation, and differentiation in three dimensions and closely resembles the circumstances found in living tissues and organs. The market includes a wide range of synthetic polymers, decellularized tissues, hydrogels, and other materials and technologies that are used to produce these 3D structures.

According to the National Institute of Health, in 2020, the total investment in various bio engineering technologies amounted to USD 5,646, an increase from USD 5,091 in 2019. According to the organdonor.gov website of the United States Health Resources and Services Administration, in October 2021, 107,103 patients were on the national organ transplant waiting list in the year 2020.

Market Dynamics:

Driver:

Regenerative medicine and tissue engineering

Opportunities for 3D cell culture scaffolds to promote the production of functional tissues and organs for transplantation are offered by the growing interest in regenerative medicine and tissue engineering applications. Additionally, the market acquires from the growing demand for more reliable in vitro models in drug development, providing the chance to build better prediction tools for testing medication efficacy and safety.

Restraint:

Cost, standardization and complexity

Due to the wide range of scaffold materials and technologies available, creating standardized protocols for 3D cell culture scaffold-based research can be difficult. However, they can be more expensive than conventional 2D culture techniques, 3D cell culture scaffolds and related technologies may not be as widely used, especially in environments with limited resources.

Opportunity:

Technology advancements and cancer research

The accuracy and physiological relevance of in vitro cell models are being improved by ongoing developments in 3D cell culture techniques, including scaffold-based approaches, which are increasing the demand for scaffolds. Additionally, for cancer research and medication testing, 3D cell culture models using scaffolds allow for more complicated and realistic tumor models, which leads to better therapeutic approaches.

Threat:

Regulatory barriers

Regulations can cause delays and higher costs in the 3D cell culture scaffold business, particularly when utilized for drug testing and safety evaluations. Complex regulatory regulations may apply to the use of 3D cell culture models, particularly in drug development and toxicity testing. It can take a lot of resources and time to comply with these rules and get the required approvals.

COVID-19 Impact:

The pandemic affected the availability of essential materials and components needed to produce 3D cell culture scaffolds by disrupting global supply lines. Manufacturers experienced delays and higher expenses as a result. Budget restrictions in the research and development divisions during the pandemic were caused by economic uncertainty, which might have had an impact on investments in 3D cell culture scaffolds.

The synthetic polymers segment is expected to be the largest during the forecast period

Synthetic Polymers segment is expected to hold the largest share over the forecast period. A crucial component of the market for 3D cell culture scaffolds, the synthetic polymer sector provides an extensive range of designed materials with specific qualities for developing three-dimensional cell culture settings. Additionally, in order to create complex cell culture conditions for personalized treatment, synthetic polymers are crucial because of their versatility and biocompatibility. They provide the chance for advancements in regenerative medicine by facilitating the development of functioning tissues and organs.

The biopharmaceutical segment is expected to have the highest CAGR during the forecast period

Biopharmaceutical segment is expected to have the highest CAGR. 3D cell culture scaffolds are used by biopharmaceutical businesses to accelerate the drug discovery and development process. These scaffolds offer a more exact approximation of in vivo circumstances, enabling more accurate efficacy and safety assessments of drug candidates. Additionally, they are crucial in the production of physiologically accurate cell models for inquiries on toxicity, cancer, and the design of targeted medicines. The market for 3D cell culture scaffolds aids biopharmaceutical companies in the pursuit of personalized medicine by enabling them to customize medicines based on individual patient responses.

Region with largest share:

The largest share was held by the Asia-Pacific area. Precision medicine and tissue regeneration, which rely on 3D cell culture models, are becoming more and more important as the area develops as a center for medical tourism and high-tech healthcare services. Additionally, investments in healthcare and life sciences are being fueled by the robust economic growth of nations like China and India, which is raising the demand for cutting-edge cell culture technologies.

Region with highest CAGR:

Asia Pacific region is expected to grow rapidly. The prevalence of cardiovascular disorders in the area has prompted an examination of vascular biology and the creation of 3D cell culture scaffold in an effort to better understand these illnesses and create therapeutic remedies. Moreover, the Asia Pacific region's pharmaceutical sector uses 3D cell culture models to test cardiovascular medications and assess how they affect vascular biology, which helps in drug development.

Key players in the market:

Some of the key players in 3D Cell Culture Scaffold Market include: 3D Biotek, Corning Incorporated, Greiner Bio-One, InSphero AG, Lonza Group, Merck KGaA, N3d Bioscience, Nanofiber Solutions, Reprocell Incorporated, Synthecon Incorporated, TARA Biosystems and Thermo Fisher Scientific.

Key Developments:

In October 2023, Thermo Fisher expands US manufacturing plant to support biologics. The US-based biotechnology and medical equipment company has added multiple biologic manufacturing facilities to accommodate a growing demand for these therapies.

In October 2023, Thermo Fisher Scientific, the world leader in serving science, expanded its manufacturing capacity in St. Louis to support biologic therapies for diseases ranging from cancers to auto immune conditions to rare genetic disorders.

Types Covered:

  • Fiber
  • Hydrogel
  • Decellularized Scaffolds
  • Synthetic Polymers
  • Other Types

Applications Covered:

  • Biopharmaceutical
  • Scientific Research
  • Vascular Biology
  • Tissue Engineering
  • Drug Discovery and Development
  • Bioprinting
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options::

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global 3D Cell Culture Scaffold Market, By Type

  • 5.1 Introduction
  • 5.2 Fiber
  • 5.3 Hydrogel
  • 5.4 Decellularized Scaffolds
  • 5.5 Synthetic Polymers
  • 5.6 Other Types

6 Global 3D Cell Culture Scaffold Market, By Application

  • 6.1 Introduction
  • 6.2 Biopharmaceutical
  • 6.3 Scientific Research
  • 6.4 Vascular Biology
  • 6.5 Tissue Engineering
  • 6.6 Drug Discovery and Development
  • 6.7 Bioprinting
  • 6.8 Other Applications

7 Global 3D Cell Culture Scaffold Market, By Geography

  • 7.1 Introduction
  • 7.2 North America
    • 7.2.1 US
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 Italy
    • 7.3.4 France
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 New Zealand
    • 7.4.6 South Korea
    • 7.4.7 Rest of Asia Pacific
  • 7.5 South America
    • 7.5.1 Argentina
    • 7.5.2 Brazil
    • 7.5.3 Chile
    • 7.5.4 Rest of South America
  • 7.6 Middle East & Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 Qatar
    • 7.6.4 South Africa
    • 7.6.5 Rest of Middle East & Africa

8 Key Developments

  • 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 8.2 Acquisitions & Mergers
  • 8.3 New Product Launch
  • 8.4 Expansions
  • 8.5 Other Key Strategies

9 Company Profiling

  • 9.1 3D Biotek
  • 9.2 Corning Incorporated
  • 9.3 Greiner Bio-One
  • 9.4 InSphero AG
  • 9.5 Lonza Group
  • 9.6 Merck KGaA
  • 9.7 N3d Bioscience
  • 9.8 Nanofiber Solutions
  • 9.9 Reprocell Incorporated
  • 9.10 Synthecon Incorporated
  • 9.11 TARA Biosystems
  • 9.12 Thermo Fisher Scientific

List of Tables

  • Table 1 Global 3D Cell Culture Scaffold Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global 3D Cell Culture Scaffold Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global 3D Cell Culture Scaffold Market Outlook, By Fiber (2021-2030) ($MN)
  • Table 4 Global 3D Cell Culture Scaffold Market Outlook, By Hydrogel (2021-2030) ($MN)
  • Table 5 Global 3D Cell Culture Scaffold Market Outlook, By Decellularized Scaffolds (2021-2030) ($MN)
  • Table 6 Global 3D Cell Culture Scaffold Market Outlook, By Synthetic Polymers (2021-2030) ($MN)
  • Table 7 Global 3D Cell Culture Scaffold Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 8 Global 3D Cell Culture Scaffold Market Outlook, By Application (2021-2030) ($MN)
  • Table 9 Global 3D Cell Culture Scaffold Market Outlook, By Biopharmaceutical (2021-2030) ($MN)
  • Table 10 Global 3D Cell Culture Scaffold Market Outlook, By Scientific Research (2021-2030) ($MN)
  • Table 11 Global 3D Cell Culture Scaffold Market Outlook, By Vascular Biology (2021-2030) ($MN)
  • Table 12 Global 3D Cell Culture Scaffold Market Outlook, By Tissue Engineering (2021-2030) ($MN)
  • Table 13 Global 3D Cell Culture Scaffold Market Outlook, By Drug Discovery and Development (2021-2030) ($MN)
  • Table 14 Global 3D Cell Culture Scaffold Market Outlook, By Bioprinting (2021-2030) ($MN)
  • Table 15 Global 3D Cell Culture Scaffold Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 16 North America 3D Cell Culture Scaffold Market Outlook, By Country (2021-2030) ($MN)
  • Table 17 North America 3D Cell Culture Scaffold Market Outlook, By Type (2021-2030) ($MN)
  • Table 18 North America 3D Cell Culture Scaffold Market Outlook, By Fiber (2021-2030) ($MN)
  • Table 19 North America 3D Cell Culture Scaffold Market Outlook, By Hydrogel (2021-2030) ($MN)
  • Table 20 North America 3D Cell Culture Scaffold Market Outlook, By Decellularized Scaffolds (2021-2030) ($MN)
  • Table 21 North America 3D Cell Culture Scaffold Market Outlook, By Synthetic Polymers (2021-2030) ($MN)
  • Table 22 North America 3D Cell Culture Scaffold Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 23 North America 3D Cell Culture Scaffold Market Outlook, By Application (2021-2030) ($MN)
  • Table 24 North America 3D Cell Culture Scaffold Market Outlook, By Biopharmaceutical (2021-2030) ($MN)
  • Table 25 North America 3D Cell Culture Scaffold Market Outlook, By Scientific Research (2021-2030) ($MN)
  • Table 26 North America 3D Cell Culture Scaffold Market Outlook, By Vascular Biology (2021-2030) ($MN)
  • Table 27 North America 3D Cell Culture Scaffold Market Outlook, By Tissue Engineering (2021-2030) ($MN)
  • Table 28 North America 3D Cell Culture Scaffold Market Outlook, By Drug Discovery and Development (2021-2030) ($MN)
  • Table 29 North America 3D Cell Culture Scaffold Market Outlook, By Bioprinting (2021-2030) ($MN)
  • Table 30 North America 3D Cell Culture Scaffold Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 31 Europe 3D Cell Culture Scaffold Market Outlook, By Country (2021-2030) ($MN)
  • Table 32 Europe 3D Cell Culture Scaffold Market Outlook, By Type (2021-2030) ($MN)
  • Table 33 Europe 3D Cell Culture Scaffold Market Outlook, By Fiber (2021-2030) ($MN)
  • Table 34 Europe 3D Cell Culture Scaffold Market Outlook, By Hydrogel (2021-2030) ($MN)
  • Table 35 Europe 3D Cell Culture Scaffold Market Outlook, By Decellularized Scaffolds (2021-2030) ($MN)
  • Table 36 Europe 3D Cell Culture Scaffold Market Outlook, By Synthetic Polymers (2021-2030) ($MN)
  • Table 37 Europe 3D Cell Culture Scaffold Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 38 Europe 3D Cell Culture Scaffold Market Outlook, By Application (2021-2030) ($MN)
  • Table 39 Europe 3D Cell Culture Scaffold Market Outlook, By Biopharmaceutical (2021-2030) ($MN)
  • Table 40 Europe 3D Cell Culture Scaffold Market Outlook, By Scientific Research (2021-2030) ($MN)
  • Table 41 Europe 3D Cell Culture Scaffold Market Outlook, By Vascular Biology (2021-2030) ($MN)
  • Table 42 Europe 3D Cell Culture Scaffold Market Outlook, By Tissue Engineering (2021-2030) ($MN)
  • Table 43 Europe 3D Cell Culture Scaffold Market Outlook, By Drug Discovery and Development (2021-2030) ($MN)
  • Table 44 Europe 3D Cell Culture Scaffold Market Outlook, By Bioprinting (2021-2030) ($MN)
  • Table 45 Europe 3D Cell Culture Scaffold Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 46 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Country (2021-2030) ($MN)
  • Table 47 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Type (2021-2030) ($MN)
  • Table 48 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Fiber (2021-2030) ($MN)
  • Table 49 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Hydrogel (2021-2030) ($MN)
  • Table 50 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Decellularized Scaffolds (2021-2030) ($MN)
  • Table 51 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Synthetic Polymers (2021-2030) ($MN)
  • Table 52 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 53 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Application (2021-2030) ($MN)
  • Table 54 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Biopharmaceutical (2021-2030) ($MN)
  • Table 55 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Scientific Research (2021-2030) ($MN)
  • Table 56 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Vascular Biology (2021-2030) ($MN)
  • Table 57 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Tissue Engineering (2021-2030) ($MN)
  • Table 58 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Drug Discovery and Development (2021-2030) ($MN)
  • Table 59 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Bioprinting (2021-2030) ($MN)
  • Table 60 Asia Pacific 3D Cell Culture Scaffold Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 61 South America 3D Cell Culture Scaffold Market Outlook, By Country (2021-2030) ($MN)
  • Table 62 South America 3D Cell Culture Scaffold Market Outlook, By Type (2021-2030) ($MN)
  • Table 63 South America 3D Cell Culture Scaffold Market Outlook, By Fiber (2021-2030) ($MN)
  • Table 64 South America 3D Cell Culture Scaffold Market Outlook, By Hydrogel (2021-2030) ($MN)
  • Table 65 South America 3D Cell Culture Scaffold Market Outlook, By Decellularized Scaffolds (2021-2030) ($MN)
  • Table 66 South America 3D Cell Culture Scaffold Market Outlook, By Synthetic Polymers (2021-2030) ($MN)
  • Table 67 South America 3D Cell Culture Scaffold Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 68 South America 3D Cell Culture Scaffold Market Outlook, By Application (2021-2030) ($MN)
  • Table 69 South America 3D Cell Culture Scaffold Market Outlook, By Biopharmaceutical (2021-2030) ($MN)
  • Table 70 South America 3D Cell Culture Scaffold Market Outlook, By Scientific Research (2021-2030) ($MN)
  • Table 71 South America 3D Cell Culture Scaffold Market Outlook, By Vascular Biology (2021-2030) ($MN)
  • Table 72 South America 3D Cell Culture Scaffold Market Outlook, By Tissue Engineering (2021-2030) ($MN)
  • Table 73 South America 3D Cell Culture Scaffold Market Outlook, By Drug Discovery and Development (2021-2030) ($MN)
  • Table 74 South America 3D Cell Culture Scaffold Market Outlook, By Bioprinting (2021-2030) ($MN)
  • Table 75 South America 3D Cell Culture Scaffold Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 76 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Country (2021-2030) ($MN)
  • Table 77 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Type (2021-2030) ($MN)
  • Table 78 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Fiber (2021-2030) ($MN)
  • Table 79 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Hydrogel (2021-2030) ($MN)
  • Table 80 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Decellularized Scaffolds (2021-2030) ($MN)
  • Table 81 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Synthetic Polymers (2021-2030) ($MN)
  • Table 82 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 83 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Application (2021-2030) ($MN)
  • Table 84 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Biopharmaceutical (2021-2030) ($MN)
  • Table 85 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Scientific Research (2021-2030) ($MN)
  • Table 86 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Vascular Biology (2021-2030) ($MN)
  • Table 87 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Tissue Engineering (2021-2030) ($MN)
  • Table 88 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Drug Discovery and Development (2021-2030) ($MN)
  • Table 89 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Bioprinting (2021-2030) ($MN)
  • Table 90 Middle East & Africa 3D Cell Culture Scaffold Market Outlook, By Other Applications (2021-2030) ($MN)